ArticleKidney international reports2023

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy.

Frederick W K Tam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.